Skip to content

Construction of an early diagnosis and prognosis prediction system for sepsis based on Raman spectroscopy

Study group on early diagnosis and prognosis of sepsis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052560
Enrollment
Unknown
Registered
2021-10-31
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

Gold Standard:Diagnosis criteria of sepsis-3.
Spectra&#32
of&#32
serum,&#32
urine,&#32
blood&#32
and&#32
serum&#32
markers&#32
(CRP,&#32
SAA&#32

Sponsors

The First Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. The adult septic patients met the criteria of sepsis-3; 2. Adult patients with common Infections (without infection-related organ failure); 3. Adult health control (Health checkers); 4. Willing to be included in the study and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. The subjects had any active autoimmune disease or had a history of autoimmune disease; 2. Human Immunodeficiency Virus infection, mycobacterium tuberculosis infection, Hepatitis B virus virus infection; 3. Patients with tumors (including solid tumors and hematological system tumors); 4. Cognitive impairment, intellectual impairment, mental impairment, consciousness impairment, hearing impairment unable to cooperate; 5. Received hormones or immunosuppressants therapy 14 days before the study were included; 6. Pregnant and lactating women; 7. The estimated survival time is less than 6 months due to other serious diseases; 8. Have participated in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Raman spectra;Sensitivity, specificity, accuracy;

Countries

China

Contacts

Public ContactZhang Zhanqin

The First Affiliated Hospital of Xi'an Jiaotong University

zhangzhanqin12@sina.com+86 13259983110

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026